Skip to main content
SpringerLink
Log in

Methodological Challenges Associated with the Measurement of Medication Adherence in Patients with Cardiovascular Disease

  • Reference work entry
  • First Online:
Handbook of Cardiovascular Behavioral Medicine

Abstract

Medication adherence is at the cornerstone of effective treatment and management of cardiovascular disease (CVD). Despite the availability of numerous efficacious medications to manage CVD, adherence to prescribed medications remains suboptimal. While much work has been done to understand the barriers to medication adherence in patients with CVD, an equally problematic area is the impact that the measure selected to assess medication adherence has on the intended outcomes. One of the primary challenges to the field is the notion that no single measure can be considered the “gold standard” for all types of research or clinic settings. In this chapter, we review the evidence to date that addresses the methods to assess medication adherence in patients with CVD. Specifically, the objectives of this chapter are (1) to review the importance of selecting accurate measures to assess medication adherence and common challenges of adherence measurement, (2) to discuss the strengths and weaknesses of medication adherence measures currently utilized in the CVD literature and discuss their relation to CVD-related outcomes, (3) to evaluate the level of agreement among the various adherence measures, and (4) to highlight special considerations when selecting self-report adherence measures in particular subgroups. Finally, we conclude with a discussion of current innovations in methods to assess medication adherence and offer future implications for research and clinical applications.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 549.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Addison CC, Jenkins BW, Sarpong D, Wilson G, Champion C, Sims J, White MS (2011) Relationship between medication use and cardiovascular disease health outcomes in the Jackson heart study. Int J Environ Res Public Health 8(6):2505–2515

    Article  PubMed  PubMed Central  Google Scholar 

  2. Aloia MS, Goodwin MS, Velicer WF, Arnedt JT, Zimmerman M, Skrekas J, Harris S, Millman RP (2008) Time series analysis of treatment adherence patterns in individuals with obstructive sleep apnea. Ann Behav Med 36(1):44–53

    Article  PubMed  Google Scholar 

  3. Andrejak M, Genes N, Vaur L, Poncelet P, Clerson P, Carre A (2000) Electronic pill-boxes in the evaluation of antihypertensive treatment compliance: comparison of once daily versus twice daily regimen. Am J Hypertens 13(2):184–190

    Article  PubMed  Google Scholar 

  4. Asche C, LaFleur J, Conner C (2011) A review of diabetes treatment adherence and the association with clinical and economic outcomes. Clin Ther 33(1):74–109. doi:S0149-2918(11)00066-X

    Article  PubMed  Google Scholar 

  5. Bangsberg DR, Hecht FM, Clague H, Charlebois ED, Ciccarone D, Chesney M, Moss A (2001) Provider assessment of adherence to HIV antiretroviral therapy. J Acquir Immune Defic Syndr 26(5):435–442

    Article  PubMed  Google Scholar 

  6. Bates TR, Connaughton VM, Watts GF (2009) Non-adherence to statin therapy: a major challenge for preventive cardiology. Expert Opin Pharmacother 10(18):2973–2985

    Article  PubMed  Google Scholar 

  7. Beach MC, Keruly J, Moore RD (2006) Is the quality of the patient-provider relationship associated with better adherence and health outcomes for patients with HIV? J Gen Intern Med 21(6):661–665

    Article  PubMed  PubMed Central  Google Scholar 

  8. Beach MC, Duggan PS, Moore RD (2007) Is patients’ preferred involvement in health decisions related to outcomes for patients with HIV? J Gen Intern Med 22(8):1119–1124

    Article  PubMed  PubMed Central  Google Scholar 

  9. Benson J, Britten N (2002) Patients’ decisions about whether or not to take antihypertensive drugs: qualitative study. BMJ 325(7369):873

    Article  PubMed  PubMed Central  Google Scholar 

  10. Berg KM, Arnsten JH (2006) Practical and conceptual challenges in measuring antiretroviral adherence. J Acquir Immune Defic Syndr 43(Suppl 1):S79–S87

    Article  PubMed  PubMed Central  Google Scholar 

  11. Bermingham M, Hayden J, Dawkins I, Miwa S, Gibson D, McDonald K, Ledwidge M (2011) Prospective analysis of LDL-C goal achievement and self-reported medication adherence among statin users in primary care. Clin Ther. doi:S0149-2918(11)00492-9 [pii]

    Google Scholar 

  12. Bertholet N, Favrat B, Fallab-Stubi CL, Brunner HR, Burnier M (2000) Why objective monitoring of compliance is important in the Management of Hypertension. J Clin Hypertens (Greenwich, Conn) 2(4):258–262

    Google Scholar 

  13. Bleser L, Geest S, Vincke B, Ruppar T, Vanhaecke J, Dobbels F (2011) How to test electronic adherence monitoring devices for use in daily life: a conceptual framework. Comput Inform Nurs. https://doi.org/10.1097/NCN.0b013e31821a1555

  14. Bosworth HB, Powers B, Grubber JM, Thorpe CT, Olsen MK, Orr M, Oddone EZ (2008) Racial differences in blood pressure control: potential explanatory factors. J Gen Intern Med 23(5):692–698

    Article  PubMed  PubMed Central  Google Scholar 

  15. Bosworth HB, Granger BB, Mendys P, Brindis R, Burkholder R, Czajkowski SM, Daniel JG, Ekman I, Ho M, Johnson M, Kimmel SE, Liu LZ, Musaus J, Shrank WH, Whalley Buono E, Weiss K, Granger CB (2011) Medication adherence: a call for action. Am Heart J 162(3):412–424

    Article  PubMed  PubMed Central  Google Scholar 

  16. Bramley TJ, Gerbino PP, Nightengale BS, Frech-Tamas F (2006) Relationship of blood pressure control to adherence with antihypertensive monotherapy in 13 managed care organizations. J Manag Care Pharm 12(3):239–245

    Article  PubMed  Google Scholar 

  17. Brath H, Morak J, Kastenbauer T, Modre-Osprian R, Strohner-Kastenbauer H, Schwarz M, Kort W, Schreier G (2013) Mobile health (mHealth) based medication adherence measurement - a pilot trial using electronic blisters in diabetes patients. Br J Clin Pharmacol 76(Suppl 1):47–55

    Article  PubMed  PubMed Central  Google Scholar 

  18. Braunstein JB, Sherber NS, Schulman SP, Ding EL, Powe NR (2008) Race, medical researcher distrust, perceived harm, and willingness to participate in cardiovascular prevention trials. Medicine (Baltimore) 87(1):1–9

    Article  Google Scholar 

  19. Briesacher BA, Andrade SE, Fouayzi H, Chan KA (2008) Comparison of drug adherence rates among patients with seven different medical conditions. Pharmacotherapy 28(4):437–443

    Article  PubMed  PubMed Central  Google Scholar 

  20. Bryson CL, Au DH, Young B, McDonell MB, Fihn SD (2007) A refill adherence algorithm for multiple short intervals to estimate refill compliance (ReComp). Med Care 45(6):497–504

    Article  PubMed  Google Scholar 

  21. Bultman DC, Svarstad BL (2000) Effects of physician communication style on client medication beliefs and adherence with antidepressant treatment. Patient Educ Couns 40(2):173–185

    Article  PubMed  Google Scholar 

  22. Bureau USC (2011) Overview of race and hispanic origin: 2010.

    Google Scholar 

  23. Burnier M (2006) Medication adherence and persistence as the cornerstone of effective antihypertensive therapy. Am J Hypertens 19(11):1190–1196

    Article  PubMed  Google Scholar 

  24. Burnier M, Schneider MP, Chiolero A, Stubi CL, Brunner HR (2001) Electronic compliance monitoring in resistant hypertension: the basis for rational therapeutic decisions. J Hypertens 19(2):335–341

    Article  PubMed  Google Scholar 

  25. Burnier M, Brown RE, Ong SH, Keskinaslan A, Khan ZM (2009) Issues in blood pressure control and the potential role of single-pill combination therapies. Int J Clin Pract 63(5):790–798

    Article  PubMed  Google Scholar 

  26. Burt VL, Cutler JA, Higgins M, Horan MJ, Labarthe D, Whelton P, Brown C, Roccella EJ (1995) Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population. Data from the health examination surveys, 1960 to 1991. Hypertension 26(1):60–69

    Article  PubMed  Google Scholar 

  27. Cene CW, Roter D, Carson KA, Miller ER 3rd, Cooper LA (2009) The effect of patient race and blood pressure control on patient-physician communication. J Gen Intern Med 24(9):1057–1064

    Article  PubMed  PubMed Central  Google Scholar 

  28. CerePak® Smart Adherance Packaging (2017) (MeadWestvaco Corporation.) https://www.westrock.com/en/products/folding-cartons/cerepak. Accessed 26 June 2017

  29. Cherry SB, Benner JS, Hussein MA, Tang SS, Nichol MB (2009) The clinical and economic burden of nonadherence with antihypertensive and lipid-lowering therapy in hypertensive patients. Value Health 12(4):489–497

    Article  PubMed  Google Scholar 

  30. Choo PW, Rand CS, Inui TS, Lee ML, Cain E, Cordeiro-Breault M, Canning C, Platt R (1999) Validation of patient reports, automated pharmacy records, and pill counts with electronic monitoring of adherence to antihypertensive therapy. Med Care 37(9):846–857

    Article  PubMed  Google Scholar 

  31. Choo PW, Rand CS, Inui TS, Lee MT, Canning C, Platt R (2001) Derivation of adherence metrics from electronic dosing records. J Clin Epidemiol 54(6):619–626

    Article  PubMed  Google Scholar 

  32. Chui MA, Deer M, Bennett SJ, Tu W, Oury S, Brater DC, Murray MD (2003) Association between adherence to diuretic therapy and health care utilization in patients with heart failure. Pharmacotherapy 23(3):326–332

    Article  PubMed  Google Scholar 

  33. Ciechanowski PS, Katon WJ, Russo JE (2000) Depression and diabetes: impact of depressive symptoms on adherence, function, and costs. Arch Intern Med 160(21):3278–3285

    Article  PubMed  Google Scholar 

  34. Clark NM, Dodge JA (1999) Exploring self-efficacy as a predictor of disease management. Health Educ Behav 26(1):72–89

    Article  PubMed  Google Scholar 

  35. Craig HM (1985) Accuracy of indirect measures of medication compliance in hypertension. Res Nurs Health 8(1):61–66

    Article  PubMed  Google Scholar 

  36. Cramer JA, Mattson RH, Prevey ML, Scheyer RD, Ouellette VL (1989) How often is medication taken as prescribed? A novel assessment technique. JAMA 261(22):3273–3277

    Article  PubMed  Google Scholar 

  37. Cramer JA, Roy A, Burrell A, Fairchild CJ, Fuldeore MJ, Ollendorf DA, Wong PK (2008) Medication compliance and persistence: terminology and definitions. Value Health 11(1):44–47

    Article  PubMed  Google Scholar 

  38. Denhaerynck K, Schafer-Keller P, Young J, Steiger J, Bock A, De Geest S (2008) Examining assumptions regarding valid electronic monitoring of medication therapy: development of a validation framework and its application on a European sample of kidney transplant patients. BMC Med Res Methodol 8:5. doi:1471-2288-8-5 [pii]

    Article  PubMed  PubMed Central  Google Scholar 

  39. Dennison CR, Peer N, Steyn K, Levitt NS, Hill MN (2007) Determinants of hypertension care and control among peri-urban Black South Africans: the HiHi study. Ethn Dis 17(3):484–491

    PubMed  Google Scholar 

  40. DiCarlo L, Moon G, Intondi A, Duck R, Frank J, Hafazi H, Behzadi Y, Robertson T, Costello B, Savage G, Zdeblick M (2012) A digital health solution for using and managing medications: wirelessly observed therapy. IEEE Pulse 3(5):23–26

    Article  PubMed  Google Scholar 

  41. DiMatteo MR (1994) Enhancing patient adherence to medical recommendations. JAMA 271(1):79–83

    Article  PubMed  Google Scholar 

  42. DiMatteo MR (1995) Patient adherence to pharmacotherapy: the importance of effective communication. Formulary 30(10):596–598, 601-592, 605

    PubMed  Google Scholar 

  43. DiMatteo MR (2004a) Social support and patient adherence to medical treatment: a meta-analysis. Health Psychol 23(2):207–218

    Article  PubMed  Google Scholar 

  44. DiMatteo MR (2004b) Variations in patients’ adherence to medical recommendations: a quantitative review of 50 years of research. Med Care 42(3):200–209

    Article  PubMed  Google Scholar 

  45. DiMatteo MR, Haskard KB (2006) Further challenges in adherence research: measurements, methodologies, and mental health care. Med Care 44(4):297–299

    Article  PubMed  Google Scholar 

  46. DiMatteo MR, Giordani PJ, Lepper HS, Croghan TW (2002) Patient adherence and medical treatment outcomes: a meta-analysis. Med Care 40(9):794–811. https://doi.org/10.1097/01.MLR.0000024612.61915.2D

    Article  PubMed  Google Scholar 

  47. DiMatteo MR, Haskard KB, Williams SL (2007) Health beliefs, disease severity, and patient adherence: a meta-analysis. Med Care 45(6):521–528

    Article  PubMed  Google Scholar 

  48. Doshi JA, Zhu J, Lee BY, Kimmel SE, Volpp KG (2009) Impact of a prescription copayment increase on lipid-lowering medication adherence in veterans. Circulation 119(3):390–397

    Article  PubMed  PubMed Central  Google Scholar 

  49. Dragomir A, Cote R, White M, Lalonde L, Blais L, Berard A, Perreault S (2010) Relationship between adherence level to statins, clinical issues and health-care costs in real-life clinical setting. Value Health 13(1):87–94

    Article  PubMed  Google Scholar 

  50. Egan BM, Lackland DT, Cutler NE (2003) Awareness, knowledge, and attitudes of older americans about high blood pressure: implications for health care policy, education, and research. Arch Intern Med 163(6):681–687

    Article  PubMed  Google Scholar 

  51. Farmer KC (1999) Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice. Clin Ther 21(6):1074–1090. discussion 1073

    Article  PubMed  Google Scholar 

  52. Feinstein AR (1990) On white-coat effects and the electronic monitoring of compliance. Arch Intern Med 150(7):1377–1378

    Article  PubMed  Google Scholar 

  53. Fennie KP, Bova CA, Williams AB (2006) Adjusting and censoring electronic monitoring device data. Implications for study outcomes. J Acquir Immune Defic Syndr 43(Suppl 1):S88–S95

    Article  PubMed  Google Scholar 

  54. Fodor GJ, Kotrec M, Bacskai K, Dorner T, Lietava J, Sonkodi S, Rieder A, Turton P (2005) Is interview a reliable method to verify the compliance with antihypertensive therapy? An international central-European study. J Hypertens 23(6):1261–1266

    Article  PubMed  Google Scholar 

  55. Franklin JM, Shrank WH, Pakes J, Sanfelix-Gimeno G, Matlin OS, Brennan TA, Choudhry NK (2013) Group-based trajectory models: a new approach to classifying and predicting long-term medication adherence. Med Care 51(9):789–796

    Article  PubMed  Google Scholar 

  56. Fuertes JN, Mislowack A, Bennett J, Paul L, Gilbert TC, Fontan G, Boylan LS (2007) The physician-patient working alliance. Patient Educ Couns 66(1):29–36

    Article  PubMed  Google Scholar 

  57. Galloway GP, Coyle JR, Guillen JE, Flower K, Mendelson JE (2011) A simple, novel method for assessing medication adherence: capsule photographs taken with cellular telephones. J Addict Med 5(3):170–174

    Article  PubMed  Google Scholar 

  58. Garber MC, Nau DP, Erickson SR, Aikens JE, Lawrence JB (2004) The concordance of self-report with other measures of medication adherence: a summary of the literature. Med Care 42(7):649–652

    Article  PubMed  Google Scholar 

  59. Gazmararian JA, Kripalani S, Miller MJ, Echt KV, Ren J, Rask K (2006) Factors associated with medication refill adherence in cardiovascular-related diseases: a focus on health literacy. J Gen Intern Med 21(12):1215–1221

    Article  PubMed  PubMed Central  Google Scholar 

  60. Gehi AK, Ali S, Na B, Whooley MA (2007) Self-reported medication adherence and cardiovascular events in patients with stable coronary heart disease: the heart and soul study. Arch Intern Med 167(16):1798–1803. https://doi.org/10.1001/archinte.167.16.1798

    Article  PubMed  PubMed Central  Google Scholar 

  61. George CF, Peveler RC, Heiliger S, Thompson C (2000) Compliance with tricyclic antidepressants: the value of four different methods of assessment. Br J Clin Pharmacol 50(2):166–171

    Article  PubMed  PubMed Central  Google Scholar 

  62. Glintborg B, Hillestrom PR, Olsen LH, Dalhoff KP, Poulsen HE (2007) Are patients reliable when self-reporting medication use? Validation of structured drug interviews and home visits by drug analysis and prescription data in acutely hospitalized patients. J Clin Pharmacol 47(11):1440–1449

    Article  PubMed  Google Scholar 

  63. Granger BB, Bosworth HB (2011) Medication adherence: emerging use of technology. Curr Opin Cardiol 26(4):279–287

    Article  PubMed  PubMed Central  Google Scholar 

  64. Greenwood A (2009) Simple measures can encourage African Americans to join clinical trials. http://www.cancer.gov/aboutnci/ncicancerbulletin/archive/2009/042109/page6. Accessed 21 Sept 2011

  65. Gross R, Bilker WB, Friedman HM, Coyne JC, Strom BL (2002) Provider inaccuracy in assessing adherence and outcomes with newly initiated antiretroviral therapy. AIDS 16(13):1835–1837

    Article  PubMed  Google Scholar 

  66. Gurwitz JH, Goldberg RJ (2011) Age-based exclusions from cardiovascular clinical trials: implications for elderly individuals (and for all of us): comment on “the persistent exclusion of older patients from ongoing clinical trials regarding heart failure”. Arch Intern Med 171(6):557–558

    Article  PubMed  Google Scholar 

  67. Gwadry-Sridhar FH, Manias E, Zhang Y, Roy A, Yu-Isenberg K, Hughes DA, Nichol MB (2009) A framework for planning and critiquing medication compliance and persistence research using prospective study designs. Clin Ther 31(2):421–435

    Article  PubMed  Google Scholar 

  68. Hamilton GA (2003) Measuring adherence in a hypertension clinical trial. Eur J Cardiovasc Nurs 2(3):219–228

    Article  PubMed  Google Scholar 

  69. Hansen RA, Kim MM, Song L, Tu W, Wu J, Murray MD (2009) Comparison of methods to assess medication adherence and classify nonadherence. Ann Pharmacother 43(3):413–422

    Article  PubMed  Google Scholar 

  70. Hardy E, Kumar S, Peaker S, Feely M, Pullar T (1990) A comparison of a short half-life marker (low-dose isoniazid), a long half-life pharmacological indicator (low-dose phenobarbitone) and measurements of a controlled release ‘therapeutic drug’ (metoprolol, Metoros) in reflecting incomplete compliance by volunteers. Br J Clin Pharmacol 30(3):437–441

    Article  PubMed  PubMed Central  Google Scholar 

  71. Hawkshead J, Krousel-Wood MA (2007) Techniques for measuring medication adherence in hypertensive patients in outpatient settings. Dis Manag Health Outcomes 15:109–118

    Article  Google Scholar 

  72. Haynes R (1979) In: Haynes R, Taylor D, Sackert D (eds) Compliance in health care. Johns Hopkins University Press, Baltimore

    Google Scholar 

  73. Hays RD, Kravitz RL, Mazel RM, Sherbourne CD, DiMatteo MR, Rogers WH, Greenfield S (1994) The impact of patient adherence on health outcomes for patients with chronic disease in the medical outcomes study. J Behav Med 17(4):347–360

    Article  PubMed  Google Scholar 

  74. Heiat A, Gross CP, Krumholz HM (2002) Representation of the elderly, women, and minorities in heart failure clinical trials. Arch Intern Med 162(15):1682–1688

    Article  PubMed  Google Scholar 

  75. Heidenreich PA, Trogdon JG, Khavjou OA, Butler J, Dracup K, Ezekowitz MD, Finkelstein EA, Hong Y, Johnston SC, Khera A, Lloyd-Jones DM, Nelson SA, Nichol G, Orenstein D, Wilson PW, Woo YJ (2011) Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation 123(8):933–944

    Article  PubMed  Google Scholar 

  76. Heisler M, Bouknight RR, Hayward RA, Smith DM, Kerr EA (2002) The relative importance of physician communication, participatory decision making, and patient understanding in diabetes self-management. J Gen Intern Med 17(4):243–252

    Article  PubMed  PubMed Central  Google Scholar 

  77. Ho PM, Rumsfeld JS, Masoudi FA, McClure DL, Plomondon ME, Steiner JF, Magid DJ (2006) Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Arch Intern Med 166(17):1836–1841

    Article  PubMed  Google Scholar 

  78. Ho PM, Bryson CL, Rumsfeld JS (2009) Medication adherence: its importance in cardiovascular outcomes. Circulation 119(23):3028–3035

    Article  PubMed  Google Scholar 

  79. Hope CJ, Wu J, Tu W, Young J, Murray MD (2004) Association of medication adherence, knowledge, and skills with emergency department visits by adults 50 years or older with congestive heart failure. Am J Health Syst Pharm 61(19):2043–2049

    Article  PubMed  Google Scholar 

  80. Horne R, Weinman J (1999) Patients’ beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res 47(6):555–567

    Article  PubMed  Google Scholar 

  81. Horowitz B (2011) Health care IT: mobile apps show promise for medication adherence. http://www.eweek.com/c/a/Health-Care-IT/Mobile-Apps-Show-Promise-for-Medication-Adherence-828895/. Accessed 22 Sept 2011

  82. Jackevicius CA, Li P, Tu JV (2008) Prevalence, predictors, and outcomes of primary nonadherence after acute myocardial infarction. Circulation 117(8):1028–1036

    Article  PubMed  Google Scholar 

  83. Jerant A, DiMatteo R, Arnsten J, Moore-Hill M, Franks P (2008) Self-report adherence measures in chronic illness: retest reliability and predictive validity. Med Care 46(11):1134–1139

    Article  PubMed  Google Scholar 

  84. Karve S, Cleves MA, Helm M, Hudson TJ, West DS, Martin BC (2009) Good and poor adherence: optimal cut-point for adherence measures using administrative claims data. Curr Med Res Opin 25(9):2303–2310

    Article  PubMed  Google Scholar 

  85. Kim MT, Hill MN, Bone LR, Levine DM (2000) Development and testing of the Hill-Bone compliance to high blood pressure therapy scale. Prog Cardiovasc Nurs 15(3):90–96

    Article  PubMed  Google Scholar 

  86. Kim MT, Han HR, Hill MN, Rose L, Roary M (2003) Depression, substance use, adherence behaviors, and blood pressure in urban hypertensive black men. Ann Behav Med 26(1):24–31

    Article  PubMed  Google Scholar 

  87. Kim EY, Han HR, Jeong S, Kim KB, Park H, Kang E, Shin HS, Kim MT (2007) Does knowledge matter?: intentional medication nonadherence among middle-aged Korean Americans with high blood pressure. J Cardiovasc Nurs 22(5):397–404

    Article  PubMed  Google Scholar 

  88. Knafl GJ, Bova CA, Fennie KP, O’Malley JP, Dieckhaus KD, Williams AB (2010) An analysis of electronically monitored adherence to antiretroviral medications. AIDS Behav 14(4):755–768

    Article  PubMed  Google Scholar 

  89. Kressin NR, Orner MB, Manze M, Glickman ME, Berlowitz D (n.d.) Understanding contributors to racial disparities in blood pressure control. Circ Cardiovasc Qual Outcomes 3(2):173–180

    Google Scholar 

  90. Krousel-Wood M, Muntner P, Jannu A, Desalvo K, Re RN (2005) Reliability of a medication adherence measure in an outpatient setting. Am J Med Sci 330(3):128–133

    Article  PubMed  Google Scholar 

  91. Krousel-Wood M, Islam T, Webber LS, Re RN, Morisky DE, Muntner P (2009) New medication adherence scale versus pharmacy fill rates in seniors with hypertension. Am J Manag Care 15(1):59–66

    PubMed  PubMed Central  Google Scholar 

  92. Lam WY, Fresco P (2015) Medication adherence measures: an overview. Biomed Res Int 2015:217047

    Article  PubMed  PubMed Central  Google Scholar 

  93. Lee JY, Kusek JW, Greene PG, Bernhard S, Norris K, Smith D, Wilkening B, Wright JT Jr (1996) Assessing medication adherence by pill count and electronic monitoring in the African American study of kidney disease and hypertension (AASK) pilot study. Am J Hypertens 9(8):719–725

    Article  PubMed  Google Scholar 

  94. Lee JK, Grace KA, Foster TG, Crawley MJ, Erowele GI, Sun HJ, Turner PT, Sullenberger LE, Taylor AJ (2007) How should we measure medication adherence in clinical trials and practice? Ther Clin Risk Manag 3(4):685–690

    PubMed  PubMed Central  Google Scholar 

  95. Librero J, Sanfelix-Gimeno G, Peiro S (2016) Medication adherence patterns after hospitalization for coronary heart disease. A population-based study using electronic records and group-based trajectory models. PLoS One 11(8):e0161381

    Article  PubMed  PubMed Central  Google Scholar 

  96. Liu H, Golin CE, Miller LG, Hays RD, Beck CK, Sanandaji S, Christian J, Maldonado T, Duran D, Kaplan AH, Wenger NS (2001) A comparison study of multiple measures of adherence to HIV protease inhibitors. Ann Intern Med 134(10):968–977

    Article  PubMed  Google Scholar 

  97. MacLaughlin EJ, Raehl CL, Treadway AK, Sterling TL, Zoller DP, Bond CA (2005) Assessing medication adherence in the elderly: which tools to use in clinical practice? Drugs Aging 22(3):231–255

    Article  PubMed  Google Scholar 

  98. Mallion JM, Baguet JP, Siche JP, Tremel F, de Gaudemaris R (1998) Compliance, electronic monitoring and antihypertensive drugs. J Hypertens Suppl 16(1):S75–S79

    PubMed  Google Scholar 

  99. Mason BJ, Matsuyama JR, Jue SG (1995) Assessment of sulfonylurea adherence and metabolic control. Diabetes Educ 21(1):52–57

    Article  PubMed  Google Scholar 

  100. Mattson ME, Friedman LM (1984) Issues in medication adherence assessment in clinical trials of the National Heart, Lung, and Blood Institute. Control Clin Trials 5(4 Suppl):488–496

    Article  PubMed  Google Scholar 

  101. McHorney CA (2009) The adherence estimator: a brief, proximal screener for patient propensity to adhere to prescription medications for chronic disease. Curr Med Res Opin 25(1):215–238

    Article  PubMed  Google Scholar 

  102. Melloni C, Berger JS, Wang TY, Gunes F, Stebbins A, Pieper KS, Dolor RJ, Douglas PS, Mark DB, Newby LK (2010) Representation of women in randomized clinical trials of cardiovascular disease prevention. Circ Cardiovasc Qual Outcomes 3(2):135–142

    Article  PubMed  Google Scholar 

  103. Miller NH, Hill M, Kottke T, Ockene IS (1997) The multilevel compliance challenge: recommendations for a call to action. A statement for healthcare professionals. Circulation 95(4):1085–1090

    Article  PubMed  Google Scholar 

  104. Modi AC, Rausch JR, Glauser TA (2011) Patterns of nonadherence to antiepileptic drug therapy in children with newly diagnosed epilepsy. JAMA 305(16):1669–1676

    Article  PubMed  PubMed Central  Google Scholar 

  105. Morisky DE, DiMatteo MR (2011) Improving the measurement of self-reported medication nonadherence: response to authors. J Clin Epidemiol 64(3):255–257

    Article  PubMed  Google Scholar 

  106. Morisky DE, Green LW, Levine DM (1986) Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 24(1):67–74

    Article  PubMed  Google Scholar 

  107. Morisky DE, Malotte CK, Choi P, Davidson P, Rigler S, Sugland B, Langer M (1990) A patient education program to improve adherence rates with antituberculosis drug regimens. Health Educ Q 17(3):253–267

    Article  PubMed  Google Scholar 

  108. Morisky DE, Ang A, Krousel-Wood M, Ward HJ (2008) Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens (Greenwich, Conn) 10(5):348–354

    Article  Google Scholar 

  109. Morris AB, Li J, Kroenke K, Bruner-England TE, Young JM, Murray MD (2006) Factors associated with drug adherence and blood pressure control in patients with hypertension. Pharmacotherapy 26(4):483–492

    Article  PubMed  Google Scholar 

  110. Muntner P, Joyce C, Holt E, He J, Morisky D, Webber LS, Krousel-Wood M (2011) Defining the minimal detectable change in scores on the eight-item Morisky medication adherence scale. Ann Pharmacother 45(5):569–575

    Article  PubMed  Google Scholar 

  111. Nelson MR, Reid CM, Ryan P, Willson K, Yelland L (2006) Self-reported adherence with medication and cardiovascular disease outcomes in the second Australian National Blood Pressure Study (ANBP2). Med J Aust 185(9):487–489

    Article  PubMed  Google Scholar 

  112. New England Healthcare Institute (2009) Thinking outside the pillbox: a system wide approach to improving patient medication adherence for chronic disease

    Google Scholar 

  113. Nguyen GC, LaVeist TA, Harris ML, Datta LW, Bayless TM, Brant SR (2009) Patient trust-in-physician and race are predictors of adherence to medical management in inflammatory bowel disease. Inflamm Bowel Dis 15(8):1233–1239

    Article  PubMed  Google Scholar 

  114. Noncompliance with medication regimens. An economic tragedy. Emerging issues in pharmaceutical cost containing. (1992) National Pharmaceutical Council, Washington, DC

    Google Scholar 

  115. Norell SE (1981) Accuracy of patient interviews and estimates by clinical staff in determining medication compliance. Soc Sci Med 15(1):57–61

    Article  Google Scholar 

  116. Office CB (2012) Offsetting effects of prescription drug use on Medicare’s spending for medical services

    Google Scholar 

  117. Ogedegbe G, Harrison M, Robbins L, Mancuso CA, Allegrante JP (2004) Barriers and facilitators of medication adherence in hypertensive African Americans: a qualitative study. Ethn Dis 14(1):3–12

    PubMed  Google Scholar 

  118. Ogedegbe G, Schoenthaler A, Richardson T, Lewis L, Belue R, Espinosa E, Spencer J, Allegrante JP, Charlson ME (2007) An RCT of the effect of motivational interviewing on medication adherence in hypertensive African Americans: rationale and design. Contemp Clin Trials 28(2):169–181

    Article  PubMed  Google Scholar 

  119. Okonofua EC, Simpson KN, Jesri A, Rehman SU, Durkalski VL, Egan BM (2006) Therapeutic inertia is an impediment to achieving the healthy people 2010 blood pressure control goals. Hypertension 47(3):345–351

    Article  PubMed  Google Scholar 

  120. Orrell C, Cohen K, Leisegang R, Bangsberg DR, Wood R, Maartens G (2017) Comparison of six methods to estimate adherence in an ART-naive cohort in a resource-poor setting: which best predicts virological and resistance outcomes? AIDS Res Ther 14(1):20

    Article  PubMed  PubMed Central  Google Scholar 

  121. Osterberg L, Blaschke T (2005) Adherence to medication. N Engl J Med 353(5):487–497

    Article  PubMed  Google Scholar 

  122. Park J, Campese V (2007) Clinical characteristics of resistant hypertension: the importance of compliance and the role of diagnostic evaluation in delineating pathogenesis. J Clin Hypertens (Greenwich, Conn) 9(1 Suppl 1):7–12

    Article  Google Scholar 

  123. Park LG, Howie-Esquivel J, Chung ML, Dracup K (2014) A text messaging intervention to promote medication adherence for patients with coronary heart disease: a randomized controlled trial. Patient Educ Couns 94(2):261–268

    Article  PubMed  Google Scholar 

  124. Park LG, Howie-Esquivel J, Dracup K (2015) Electronic measurement of medication adherence. West J Nurs Res 37(1):28–49

    Article  PubMed  Google Scholar 

  125. Paterson DL, Swindells S, Mohr J, Brester M, Vergis EN, Squier C, Wagener MM, Singh N (2000) Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med 133(1):21–30

    Article  PubMed  Google Scholar 

  126. Perreault S, Dragomir A, White M, Lalonde L, Blais L, Berard A (2009) Better adherence to antihypertensive agents and risk reduction of chronic heart failure. J Intern Med 266(2):207–218

    Article  PubMed  Google Scholar 

  127. Peterson AM, Takiya L, Finley R (2003) Meta-analysis of trials of interventions to improve medication adherence. Am J Health Syst Pharm 60(7):657–665

    Article  PubMed  Google Scholar 

  128. Piette JD, Schillinger D, Potter MB, Heisler M (2003) Dimensions of patient-provider communication and diabetes self-care in an ethnically diverse population. J Gen Intern Med 18(8):624–633

    Article  PubMed  PubMed Central  Google Scholar 

  129. Pittman DG, Chen W, Bowlin SJ, Foody JM (2011) Adherence to statins, subsequent healthcare costs, and cardiovascular hospitalizations. Am J Cardiol 107(11):1662–1666

    Article  PubMed  Google Scholar 

  130. Prado JC Jr, Kupek E, Mion D Jr (2007) Validity of four indirect methods to measure adherence in primary care hypertensives. J Hum Hypertens 21(7):579–584

    Article  PubMed  Google Scholar 

  131. Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, Berry JD, Brown TM, Carnethon MR, Dai S, de Simone G, Ford ES, Fox CS, Fullerton HJ, Gillespie C, Greenlund KJ, Hailpern SM, Heit JA, Ho PM, Howard VJ, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Makuc DM, Marcus GM, Marelli A, Matchar DB, McDermott MM, Meigs JB, Moy CS, Mozaffarian D, Mussolino ME, Nichol G, Paynter NP, Rosamond WD, Sorlie PD, Stafford RS, Turan TN, Turner MB, Wong ND, Wylie-Rosett J (2011) Heart disease and stroke statistics--2011 update: a report from the American Heart Association. Circulation 123(4):e18–e209

    Article  PubMed  Google Scholar 

  132. Rolley JX, Davidson PM, Dennison CR, Ong A, Everett B, Salamonson Y (2008) Medication adherence self-report instruments: implications for practice and research. J Cardiovasc Nurs 23(6):497–505

    Article  PubMed  Google Scholar 

  133. Rose AJ, Glickman ME, D’Amore MM, Orner MB, Berlowitz D, Kressin NR (2011) Effects of daily adherence to antihypertensive medication on blood pressure control. J Clin Hypertens (Greenwich, Conn) 13(6):416–421

    Article  Google Scholar 

  134. Rossi PH, Lipsey WM, Freeman HE (2004) Evaluation: a systematic approach, 7th edn. Sage, Thousand Oaks

    Google Scholar 

  135. Roumie CL, Elasy TA, Greevy R, Griffin MR, Liu X, Stone WJ, Wallston KA, Dittus RS, Alvarez V, Cobb J, Speroff T (2006) Improving blood pressure control through provider education, provider alerts, and patient education: a cluster randomized trial. Ann Intern Med 145(3):165–175

    Article  PubMed  Google Scholar 

  136. Rudd P, Byyny RL, Zachary V, LoVerde ME, Titus C, Mitchell WD, Marshall G (1989) The natural history of medication compliance in a drug trial: limitations of pill counts. Clin Pharmacol Ther 46(2):169–176

    Article  PubMed  Google Scholar 

  137. Schedlbauer A, Schroeder K, Peters TJ, Fahey T (2004) Interventions to improve adherence to lipid lowering medication. Cochrane Database Syst Rev 4:CD004371

    Google Scholar 

  138. Schneider J, Kaplan SH, Greenfield S, Li W, Wilson IB (2004) Better physician-patient relationships are associated with higher reported adherence to antiretroviral therapy in patients with HIV infection. J Gen Intern Med 19(11):1096–1103

    Article  PubMed  PubMed Central  Google Scholar 

  139. Schoenthaler A, Ogedegbe G (2008) Patients’ perceptions of electronic monitoring devices affect medication adherence in hypertensive African Americans. Ann Pharmacother 42(5):647–652

    Article  PubMed  Google Scholar 

  140. Schroeder K, Fahey T, Ebrahim S, Peters TJ (2004a) Adherence to long-term therapies: recent WHO report provides some answers but poses even more questions. J Clin Epidemiol 57(1):2–3

    Article  PubMed  Google Scholar 

  141. Schroeder K, Fahey T, Ebrahim S (2004b) How can we improve adherence to blood pressure-lowering medication in ambulatory care? Systematic review of randomized controlled trials. Arch Intern Med 164(7):722–732

    Article  PubMed  Google Scholar 

  142. Schroeder K, Fahey T, Hay AD, Montgomery A, Peters TJ (2006) Adherence to antihypertensive medication assessed by self-report was associated with electronic monitoring compliance. J Clin Epidemiol 59(6):650–651

    Article  PubMed  Google Scholar 

  143. Schwed A, Fallab CL, Burnier M, Waeber B, Kappenberger L, Burnand B, Darioli R (1999) Electronic monitoring of compliance to lipid-lowering therapy in clinical practice. J Clin Pharmacol 39(4):402–409

    Article  PubMed  Google Scholar 

  144. Shalansky SJ, Levy AR, Ignaszewski AP (2004) Self-reported Morisky score for identifying nonadherence with cardiovascular medications. Ann Pharmacother 38(9):1363–1368

    Article  PubMed  Google Scholar 

  145. Shea S, Misra D, Ehrlich MH, Field L, Francis CK (1992) Correlates of nonadherence to hypertension treatment in an inner-city minority population. Am J Public Health 82(12):1607–1612

    Article  PubMed  PubMed Central  Google Scholar 

  146. Shi L, Liu J, Fonseca V, Walker P, Kalsekar A, Pawaskar M (2010) Correlation between adherence rates measured by MEMS and self-reported questionnaires: a meta-analysis. Health Qual Life Outcomes 8:99

    Article  PubMed  PubMed Central  Google Scholar 

  147. Shine D, McDonald J (1999) Limits of confidence in tracer compounds as a means of measuring patient compliance with medication. J Clin Pharmacol 39(12):1233–1241

    Article  PubMed  Google Scholar 

  148. Sikka R, Xia F, Aubert RE (2005) Estimating medication persistency using administrative claims data. Am J Manag Care 11(7):449–457

    PubMed  Google Scholar 

  149. Sokol MC, McGuigan KA, Verbrugge RR, Epstein RS (2005) Impact of medication adherence on hospitalization risk and healthcare cost. Med Care 43(6):521–530

    Article  PubMed  Google Scholar 

  150. Stein T, Frankel RM, Krupat E (2005) Enhancing clinician communication skills in a large healthcare organization: a longitudinal case study. Patient Educ Couns 58(1):4–12

    Article  PubMed  Google Scholar 

  151. Steiner JF, Prochazka AV (1997) The assessment of refill compliance using pharmacy records: methods, validity, and applications. J Clin Epidemiol 50(1):105–116

    Article  PubMed  Google Scholar 

  152. Stone AA, Shiffman S, Schwartz JE, Broderick JE, Hufford MR (2003) Patient compliance with paper and electronic diaries. Control Clin Trials 24(2):182–199

    Article  PubMed  Google Scholar 

  153. Straka RJ, Fish JT, Benson SR, Suh JT (1997) Patient self-reporting of compliance does not correspond with electronic monitoring: an evaluation using isosorbide dinitrate as a model drug. Pharmacotherapy 17(1):126–132

    PubMed  Google Scholar 

  154. Svarstad BL, Chewning BA, Sleath BL, Claesson C (1999) The brief medication questionnaire: a tool for screening patient adherence and barriers to adherence. Patient Educ Couns 37(2):113–124

    Article  PubMed  Google Scholar 

  155. Tamblyn R, Abrahamowicz M, Dauphinee D, Wenghofer E, Jacques A, Klass D, Smee S, Eguale T, Winslade N, Girard N, Bartman I, Buckeridge DL, Hanley JA (2010) Influence of physicians’ management and communication ability on patients’ persistence with antihypertensive medication. Arch Intern Med 170(12):1064–1072

    Article  PubMed  Google Scholar 

  156. Thompson D, Mackay T, Matthews M, Edwards J, Peters N, Connolly SB (2017) Direct adherence measurement using an ingestible sensor compared with self-reporting in high-risk cardiovascular disease patients who knew they were being measured: a prospective intervention. JMIR mHealth uHealth 5(6):e76

    Article  PubMed  PubMed Central  Google Scholar 

  157. Toobert DJ, Hampson SE, Glasgow RE (2000) The summary of diabetes self-care activities measure: results from 7 studies and a revised scale. Diabetes Care 23(7):943–950

    Article  PubMed  Google Scholar 

  158. Unni EJ, Farris KB (2009) Development of a new scale to measure self-reported medication nonadherence. Res Soc Adm Pharm

    Google Scholar 

  159. Urquhart J (1997) The electronic medication event monitor. Lessons for pharmacotherapy. Clin Pharmacokinet 32(5):345–356

    Article  PubMed  Google Scholar 

  160. van Onzenoort HA, Verberk WJ, Kessels AG, Kroon AA, Neef C, van der Kuy PH, de Leeuw PW (2010) Assessing medication adherence simultaneously by electronic monitoring and pill count in patients with mild-to-moderate hypertension. Am J Hypertens 23(2):149–154

    Article  PubMed  Google Scholar 

  161. van Onzenoort HA, Neef C, Verberk WW, van Iperen HP, de Leeuw PW, van der Kuy PH (2012) Determining the feasibility of objective adherence measurement with blister packaging smart technology. Am J Health Syst Pharm 69(10):872–879

    Article  PubMed  Google Scholar 

  162. Voils CI, Hoyle RH, Thorpe CT, Maciejewski ML, Yancy WS Jr (2011) Improving the measurement of self-reported medication nonadherence. J Clin Epidemiol 64(3):250–254

    Article  PubMed  Google Scholar 

  163. Vrijens B, Vincze G, Kristanto P, Urquhart J, Burnier M (2008) Adherence to prescribed antihypertensive drug treatments: longitudinal study of electronically compiled dosing histories. BMJ 336(7653):1114–1117

    Article  PubMed  PubMed Central  Google Scholar 

  164. Waeber B, Leonetti G, Kolloch R, McInnes GT (1999) Compliance with aspirin or placebo in the hypertension optimal treatment (HOT) study. J Hypertens 17(7):1041–1045

    Article  PubMed  Google Scholar 

  165. Wandless I, Mucklow JC, Smith A, Prudham D (1979) Compliance with prescribed medicines: a study of elderly patients in the community. J R Coll Gen Pract 29(204):391–396

    PubMed  PubMed Central  Google Scholar 

  166. Wang PS, Bohn RL, Knight E, Glynn RJ, Mogun H, Avorn J (2002) Noncompliance with antihypertensive medications: the impact of depressive symptoms and psychosocial factors. J Gen Intern Med 17(7):504–511

    Article  PubMed  PubMed Central  Google Scholar 

  167. Wetzels GE, Nelemans P, Schouten JS, Prins MH (2004) Facts and fiction of poor compliance as a cause of inadequate blood pressure control: a systematic review. J Hypertens 22(10):1849–1855

    Article  PubMed  Google Scholar 

  168. Wetzels GE, Nelemans PJ, Schouten JS, van Wijk BL, Prins MH (2006a) All that glisters is not gold: a comparison of electronic monitoring versus filled prescriptions–an observational study. BMC Health Serv Res 6:8. doi:1472-6963-6-8

    Article  PubMed  PubMed Central  Google Scholar 

  169. Wetzels G, Nelemans P, van Wijk B, Broers N, Schouten J, Prins M (2006b) Determinants of poor adherence in hypertensive patients: development and validation of the “Maastricht Utrecht adherence in hypertension (MUAH)-questionnaire”. Patient Educ Couns 64(1–3):151–158

    Article  PubMed  Google Scholar 

  170. Wetzels GE, Nelemans PJ, Schouten JS, Dirksen CD, van der Weijden T, Stoffers HE, Janknegt R, de Leeuw PW, Prins MH (2007) Electronic monitoring of adherence as a tool to improve blood pressure control. A randomized controlled trial. Am J Hypertens 20(2):119–125

    Article  PubMed  Google Scholar 

  171. Williams AB (2014) Issue brief: medication adherence and health IT

    Google Scholar 

  172. World Health Organization (2003) Adherence to long-term therapies: evidence for action. World Health Organization, Geneva

    Google Scholar 

  173. Wu JR, Moser DK, Chung ML, Lennie TA (2008a) Objectively measured, but not self-reported, medication adherence independently predicts event-free survival in patients with heart failure. J Card Fail 14(3):203–210

    Article  PubMed  PubMed Central  Google Scholar 

  174. Wu JR, Chung M, Lennie TA, Hall LA, Moser DK (2008b) Testing the psychometric properties of the medication adherence scale in patients with heart failure. Heart Lung 37(5):334–343

    Article  PubMed  PubMed Central  Google Scholar 

  175. Zeller A, Taegtmeyer A, Martina B, Battegay E, Tschudi P (2008a) Physicians’ ability to predict patients’ adherence to antihypertensive medication in primary care. Hypertens Res 31(9):1765–1771

    Article  PubMed  Google Scholar 

  176. Zeller A, Schroeder K, Peters TJ (2008b) An adherence self-report questionnaire facilitated the differentiation between nonadherence and nonresponse to antihypertensive treatment. J Clin Epidemiol 61(3):282–288

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Departments of Population Health and Medicine, New York University Grossman School of Medicine, New York, NY, USA

    Antoinette Schoenthaler

  2. Packard Health, Ann Arbor, MI, USA

    Sheba Sethi

Authors
  1. Antoinette Schoenthaler
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sheba Sethi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Antoinette Schoenthaler .

Editor information

Editors and Affiliations

  1. Department of Psychology, University of Maryland, Baltimore County, Baltimore, MD, USA

    Shari R. Waldstein

  2. Department of Medical and Clinical Psychology, Tilburg University, Tilburg, The Netherlands

    Willem J. Kop

  3. Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC, USA

    Edward C. Suarez

  4. Department of Psychiatry and Behavioral Sciences, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA

    William R. Lovallo

  5. Division of Gerontology Geriatrics and Palliative Medicine Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA

    Leslie I. Katzel

Rights and permissions

Reprints and permissions

Copyright information

© 2022 The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Schoenthaler, A., Sethi, S. (2022). Methodological Challenges Associated with the Measurement of Medication Adherence in Patients with Cardiovascular Disease. In: Waldstein, S.R., Kop, W.J., Suarez, E.C., Lovallo, W.R., Katzel, L.I. (eds) Handbook of Cardiovascular Behavioral Medicine. Springer, New York, NY. https://doi.org/10.1007/978-0-387-85960-6_18

Download citation

Publish with us

Policies and ethics

Search

Navigation